These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29380769)

  • 21. Endophthalmitis after resident-performed intravitreal bevacizumab injection.
    Falavarjani KG; Aghamirsalim M; Modarres M; Hadavandkhani A; Hashemi M; Parvaresh MM; Naseripour M; Samiy N
    Can J Ophthalmol; 2015 Feb; 50(1):33-6. PubMed ID: 25677280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bevacizumab for Intravitreal Injection: Impact of Sub-Visible Particles on the Shelf-Life of Repackaged Bevacizumab.
    Crul M; Zandvliet A; Moes JR; Veenbaas T; Smeets O
    J Ocul Pharmacol Ther; 2019; 35(6):372-375. PubMed ID: 31259653
    [No Abstract]   [Full Text] [Related]  

  • 23. The cost and safety of multidose use of palivizumab vials.
    Gooding J; Millage A; Rye AK; Lacroix R
    Clin Pediatr (Phila); 2008 Mar; 47(2):160-3. PubMed ID: 17901213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC-UV stability-indicating method.
    Feutry F; Simon N; Genay S; Lannoy D; Barthélémy C; Décaudin B; Labalette P; Odou P
    Drug Dev Ind Pharm; 2016 Jan; 42(1):166-174. PubMed ID: 26006333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of endophthalmitis rates following intravitreal injection of compounded bevacizumab, ranibizumab, and aflibercept.
    Forooghian F; Albiani DA; Kirker AW; Merkur AB
    Can J Ophthalmol; 2017 Dec; 52(6):616-619. PubMed ID: 29217032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute intraocular inflammation caused by endotoxin after intravitreal injection of counterfeit bevacizumab in Shanghai, China.
    Wang F; Yu S; Liu K; Chen FE; Song Z; Zhang X; Xu X; Sun X
    Ophthalmology; 2013 Feb; 120(2):355-61. PubMed ID: 23084126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avastin doesn't blind people, people blind people.
    Gonzalez S; Rosenfeld PJ; Stewart MW; Brown J; Murphy SP
    Am J Ophthalmol; 2012 Feb; 153(2):196-203.e1. PubMed ID: 22264942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection.
    Artunay O; Yuzbasioglu E; Rasier R; Sengül A; Bahcecioglu H
    Eye (Lond); 2009 Dec; 23(12):2187-93. PubMed ID: 19218994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endophthalmitis after intravitreal injection: the importance of viridans streptococci.
    Chen E; Lin MY; Cox J; Brown DM
    Retina; 2011 Sep; 31(8):1525-33. PubMed ID: 21878800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidose vial contamination in anesthesia.
    Arrington ME; Gabbert KC; Mazgaj PW; Wolf MT
    AANA J; 1990 Dec; 58(6):462-6. PubMed ID: 2275319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathology of streptococcus mitis/oralis endophthalmitis after intravitreal injection with bevacizumab: a report of 7 patients.
    Matthews JL; Dubovy SR; Goldberg RA; Flynn HW
    Ophthalmology; 2014 Mar; 121(3):702-8. PubMed ID: 24439760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection.
    Storey P; Dollin M; Rayess N; Pitcher J; Reddy S; Vander J; Hsu J; Garg S;
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):235-42. PubMed ID: 25940556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Counterfeit Avastin in India: Punish the Criminals, Not the Patients.
    Stewart MW; Narayanan R; Gupta V; Rosenfeld PJ; Martin DF; Chakravarthy U
    Am J Ophthalmol; 2016 Oct; 170():228-231. PubMed ID: 27287822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of MALDI-TOF mass spectrometry in an outbreak investigation of acute endophthalmitis following intravitreal injection.
    Angrup A; Krishnamoorthi S; Biswal M; Gautam V; Ray P; Agarwal A; Dogra MR; Singh R; Katoch D; Gupta V
    J Hosp Infect; 2018 Dec; 100(4):e253-e256. PubMed ID: 29605188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serratia marcescens endophthalmitis associated with intravitreal injections of bevacizumab.
    Lee SH; Woo SJ; Park KH; Kim JH; Song JH; Park KU; Heo JW; Yu HG; Yu YS; Chung H
    Eye (Lond); 2010 Feb; 24(2):226-32. PubMed ID: 19407833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACTINOMYCES NEUII ENDOPHTHALMITIS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION.
    Sahni S; Watson RM; Sheth VS
    Retin Cases Brief Rep; 2017 Summer; 11(3):281-282. PubMed ID: 27280342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the sterility and stability of insulin from multidose vials used for prolonged periods.
    Rathod M; Saravolatz L; Pohlod D; Whitehouse F; Goldman J
    Infect Control; 1985 Dec; 6(12):491-4. PubMed ID: 3935593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
    Fintak DR; Shah GK; Blinder KJ; Regillo CD; Pollack J; Heier JS; Hollands H; Sharma S
    Retina; 2008; 28(10):1395-9. PubMed ID: 18827737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.
    Inoue M; Kobayakawa S; Sotozono C; Komori H; Tanaka K; Suda Y; Matsushima H; Kinoshita S; Senoo T; Tochikubo T; Kadonosono K
    Ophthalmologica; 2011; 226(3):145-50. PubMed ID: 21811052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.